Some studies have indirectly confirmed the possible involvement of RANKL in HCC pathogenesis, pointing to a direct correlation between RANKL and the expression of the signal transducer and activator of transcription-6 (STAT6) [108]. This evidence concerns the gene STAT6 and hepatocellular carcinoma.